Vis enkel innførsel

dc.contributor.authorWogsland, Cara Ellen
dc.contributor.authorLien, Hilde Eide
dc.contributor.authorPedersen, Line
dc.contributor.authorHanjra, Pahul
dc.contributor.authorGrøndal, Sturla Magnus
dc.contributor.authorBrekken, Rolf A
dc.contributor.authorLorens, James Bradley
dc.contributor.authorHalberg, Nils Henrik
dc.date.accessioned2022-01-27T12:26:00Z
dc.date.available2022-01-27T12:26:00Z
dc.date.created2022-01-04T11:17:38Z
dc.date.issued2021
dc.identifier.issn1754-8403
dc.identifier.urihttps://hdl.handle.net/11250/2887953
dc.description.abstractObesity is a disease characterized by chronic low-grade systemic inflammation and has been causally linked to the development of 13 cancer types. Several studies have been undertaken to determine whether tumors evolving in obese environments adapt differential interactions with immune cells and whether this can be connected to disease outcome. Most of these studies have been limited to single-cell lines and tumor models and analysis of limited immune cell populations. Given the multicellular complexity of the immune system and its dysregulation in obesity, we applied high-dimensional suspension mass cytometry to investigate how obesity affects tumor immunity. We used a 36-marker immune-focused mass cytometry panel to interrogate the immune landscape of orthotopic syngeneic mouse models of pancreatic and breast cancer. Unanchored batch correction was implemented to enable simultaneous analysis of tumor cohorts to uncover the immunotypes of each cancer model and reveal remarkably model-specific immune regulation. In the E0771 breast cancer model, we demonstrate an important link to obesity with an increase in two T-cell-suppressive cell types and a decrease in CD8 T cells.en_US
dc.language.isoengen_US
dc.publisherThe Company of Biologistsen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleHigh-dimensional immunotyping of tumors grown in obese and non-obese miceen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021. Published by The Company of Biologists Ltden_US
dc.source.articlenumberdmm048977en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1242/dmm.048977
dc.identifier.cristin1974183
dc.source.journalDisease Models and Mechanisms (DMM)en_US
dc.identifier.citationDisease Models and Mechanisms. 2021, 14 (4), dmm048977.en_US
dc.source.volume14en_US
dc.source.issue4en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal